Sun Pharmaceutical (SUNPHARMA) Shareholding Pattern

NSE: SUNPHARMA • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 54.48%
FII Holding 16.12%
DII Holding 20.82%
Public Holding 5.40%
Total Shareholders 710,900
As of Dec 2025
View the latest shareholding pattern of Sun Pharmaceutical (SUNPHARMA) including promoter, FII, DII, and public holdings. Track SUNPHARMA ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See Sun Pharmaceutical stock price data download)

Sun Pharmaceutical (SUNPHARMA) Shareholding Summary

  • Promoter holding remains unchanged at 54.48% in Dec 2025
  • FII/FPI have decreased holdings from 16.55% to 16.12% in Dec 2025
  • DIIs have increased holdings from 20.24% to 20.82% in Dec 2025
  • Institutional investors have increased holdings from 36.79% to 36.94% in Dec 2025
  • Public holding has decreased from 5.53% to 5.40% in Dec 2025
  • Number of shareholders decreased from 743,877 to 710,900 in Dec 2025

SUNPHARMA Quarterly Ownership Changes

Quarter-over-quarter changes for Sun Pharmaceutical from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
-0.43%
DII Holding Change
Sept 2025 to Dec 2025
+0.58%
Public Holding Change
Sept 2025 to Dec 2025
-0.13%

Sun Pharmaceutical (SUNPHARMA) Quarterly Shareholding Trends

Visual breakdown of SUNPHARMA ownership distribution over time. Learn more about SUNPHARMA earnings report.

Promoter
FII
DII
Public
Government

Rising institutional holdings in SUNPHARMA often correlate with improved fundamentals. Check out Sun Pharmaceutical price earnings.

Sun Pharmaceutical (SUNPHARMA) Shareholding Data

Download complete SUNPHARMA ownership data for offline analysis. Discover Sun Pharmaceutical dividend payments.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 54.48% 16.12% 20.82% 0.00% 5.40% 3.18% 100.00% 710,900
Sept 2025 54.48% 16.55% 20.24% 0.00% 5.53% 3.20% 100.00% 743,877
Jun 2025 54.48% 17.26% 19.50% 0.00% 5.35% 3.42% 100.01% 723,770
Mar 2025 54.48% 17.96% 18.70% 0.00% 5.42% 3.45% 100.01% 704,983
Dec 2024 54.48% 18.05% 18.55% 0.00% 5.47% 3.46% 100.01% 689,623
Sept 2024 54.48% 18.02% 18.61% 0.00% 5.43% 3.46% 100.00% 657,317
Jun 2024 54.48% 17.23% 19.28% 0.00% 5.57% 3.44% 100.00% 673,217
Mar 2024 54.48% 17.72% 18.83% 0.00% 5.44% 3.53% 100.00% 631,392
Dec 2023 54.48% 0.00% 17.97% 0.00% 5.41% 22.13% 99.99% 612,626
Sept 2023 54.48% 16.79% 19.67% 0.00% 5.56% 3.51% 100.01% 616,588
Jun 2023 54.48% 0.00% 19.75% 0.00% 5.65% 20.12% 100.00% 624,561
Mar 2023 54.48% 0.00% 19.24% 0.00% 5.70% 20.58% 100.00% 625,252
Dec 2022 54.48% 0.00% 19.14% 0.00% 5.76% 20.63% 100.01% 643,512
Sept 2022 54.48% 0.00% 18.60% 0.00% 5.91% 21.01% 100.00% 647,167
Jun 2022 54.48% 0.00% 19.57% 0.00% 6.31% 19.64% 100.00% 662,384
Mar 2022 54.48% 0.00% 19.94% 0.00% 6.49% 19.09% 100.00% 680,800
Dec 2021 54.48% 0.00% 20.94% 0.00% 6.68% 17.90% 100.00% 675,908
Sept 2021 54.48% 0.00% 21.67% 0.00% 6.79% 17.05% 99.99% 757,366
Jun 2021 54.48% 0.00% 21.93% 0.00% 7.21% 16.38% 100.00% 709,045
Mar 2021 54.48% 0.00% 21.59% 0.00% 7.34% 16.60% 100.01% 0

SUNPHARMA promoter holding above 50% indicates strong insider confidence. Explore the Sun Pharmaceutical valuation methods for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 54.48% 16.12% 20.82% 0.00% 5.40% 3.18% 100.00% 710,900
Sept 2025 54.48% 16.55% 20.24% 0.00% 5.53% 3.20% 100.00% 743,877
Jun 2025 54.48% 17.26% 19.50% 0.00% 5.35% 3.42% 100.01% 723,770
Mar 2025 54.48% 17.96% 18.70% 0.00% 5.42% 3.45% 100.01% 704,983
Dec 2024 54.48% 18.05% 18.55% 0.00% 5.47% 3.46% 100.01% 689,623
Sept 2024 54.48% 18.02% 18.61% 0.00% 5.43% 3.46% 100.00% 657,317
Jun 2024 54.48% 17.23% 19.28% 0.00% 5.57% 3.44% 100.00% 673,217
Mar 2024 54.48% 17.72% 18.83% 0.00% 5.44% 3.53% 100.00% 631,392
Dec 2023 54.48% 0.00% 17.97% 0.00% 5.41% 22.13% 99.99% 612,626
Sept 2023 54.48% 16.79% 19.67% 0.00% 5.56% 3.51% 100.01% 616,588
Jun 2023 54.48% 0.00% 19.75% 0.00% 5.65% 20.12% 100.00% 624,561
Mar 2023 54.48% 0.00% 19.24% 0.00% 5.70% 20.58% 100.00% 625,252

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 54.48% 16.12% 20.82% 0.00% 5.40% 3.18% 100.00% 710,900
Dec 2024 54.48% 18.05% 18.55% 0.00% 5.47% 3.46% 100.01% 689,623
Dec 2023 54.48% 0.00% 17.97% 0.00% 5.41% 22.13% 99.99% 612,626
Dec 2022 54.48% 0.00% 19.14% 0.00% 5.76% 20.63% 100.01% 643,512
Dec 2021 54.48% 0.00% 20.94% 0.00% 6.68% 17.90% 100.00% 675,908

Year-over-year trends reveal long-term ownership shifts.

Understanding Sun Pharmaceutical (SUNPHARMA) Shareholding Pattern

Sun Pharmaceutical shareholding pattern reveals who owns SUNPHARMA stock and how ownership changes over time. High promoter stakes in SUNPHARMA often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your SUNPHARMA trades. SUNPHARMA book value

Combine SUNPHARMA ownership analysis with price movements and financial performance for a complete investment picture. (See SUNPHARMA 52-week high low)